During the past decade, Institute of Psychiatry and Neurology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of Psychiatry and Neurology" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Orphalan" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Ataxia Study Group" with 1 trials sponsored and "BrainsGate" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Psychiatry and Neurology" #1 collaborator was "CHDI Foundation, Inc." with 1 trials as a collaborator and "Ergomed" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Psychiatry and Neurology" are "Ischemic Stroke" (2 trials), "Schizophrenia" (2 trials), "Huntington's Disease" (1 trials), "Nightmare" (1 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "Institute of Psychiatry and Neurology" in a lesser frequency.

Most popular intervention types in "Institute of Psychiatry and Neurology" are "Device" (3 trials), "Drug" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Active Sphenopalatine Ganglion (SPG) Stimulation" (1 trials), "Antismoking intervention with intensive early follow-up" (1 trials), "Antismoking intervention with minimal early follow-up" (1 trials), "Antismoking intervention with no early follow-up" (1 trials) and "BI 425809" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Psychiatry and Neurology" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Institute of Psychiatry and Neurology". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Institute of Psychiatry and Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Psychiatry and Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".